Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Blood (2016) 128 (22): 985.

https://doi.org/10.1182/blood.V128.22.985.985

Published: 2016

Journal Articles

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Anne Kruchen, PhD, Tanja Stahl, Friederike Gieseke, PhD, Thomas MC Binder, MD, Zakir Oezcan, PhD, Roland Meisel, MD, Hermann Kreyenberg, PhD, Peter Bader, Bernd Gruhn, MD, Johann Greil, MD, Matthias Pfeiffer, MD, Michaela Doering, MD, Rupert Handgretinger, Boris Fehse, Prof, Ingo Mueller, MD

Blood (2014) 124 (21): 1242.

https://doi.org/10.1182/blood.V124.21.1242.1242

Published: 2014

Journal Articles

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Eva Rettinger, MD, Michael Merker, MD, Hermann Kreyenberg, PhD, Thomas Krenn, MD, Matthias Dürken, MD, Jörg Faber, MD PhD, Sabine Huenecke, PhD, Claudia Brehm, PhD, Melanie Bremm, PhD, Shahrzad Bakhtiar, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Thomas Klingebiel, Prof., Peter Bader

Blood (2014) 124 (21): 3953.

https://doi.org/10.1182/blood.V124.21.3953.3953

Published: 2014

Journal Articles

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, PhD, Arend von Stackelberg, Cornelia Eckert, PhD, Meisel Roland, MD, Pötschger Ulrike, MD, Daniel Stachel, MD, Martin Schrappe, MD, Andre Schrauder, MD, Ansgar Schulz, MD, Peter Lang, MD, Ingo Mueller, MD, Michael H. Albert, MD, Thomas Klingebiel, MD, Christina Peters, MD

Blood (2013) 122 (21): 1995.

https://doi.org/10.1182/blood.V122.21.1995.1995

Published: 2013

Journal Articles

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Andre Manfred Willasch, MD, Eva Rettinger, MD, Marion Zabel, MD, Hermann Kreyenberg, PhD, Vida Meyer, Arndt Borkhardt, MD, Markus Metzler, MD, Bernhard Kremens, MD, Brigitte Strahm, MD, Wilhelm Woessmann, MD, Christine Mauz-Koerholz, MD, Bernd Gruhn, Stefan Burdach, MD, Michael H Albert, MD, Paul G. Schlegel, MD, Thomas Klingebiel, MD, Peter Bader

Blood (2013) 122 (21): 411.

https://doi.org/10.1182/blood.V122.21.411.411

Published: 2013

Journal Articles

Phenotypic and Functional Characterization of Mesenchymal Stromal Cells Derived from CD271 + - Bone Marrow Mononuclear Cells and Mesenchymal Stromal Cells Derived through Plastic Adherence.

Selim Kuci, MD, PhD, Kathrin Puetsch, TA, Zyrafete Kuci, MD., Sabine Huenecke, PhD., Hermann Kreyenberg, PhD., Chandra Sekhar Amara, M.Sci., Christoph Piechaczek, PhD., Ulrike Koehl, MD., PhD., Thomas Klingebiel, MD., Peter Bader, MD.

Blood (2007) 110 (11): 1921.

https://doi.org/10.1182/blood.V110.11.1921.1921

Published: 2007

NARROW

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Phenotypic and Functional Characterization of Mesenchymal Stromal Cells Derived from CD271 + - Bone Marrow Mononuclear Cells and Mesenchymal Stromal Cells Derived through Plastic Adherence.

Email alerts

ASH Publications

American Society of Hematology

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Phenotypic and Functional Characterization of Mesenchymal Stromal Cells Derived from CD271 + - Bone Marrow Mononuclear Cells and Mesenchymal Stromal Cells Derived through Plastic Adherence.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only